These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12678727)

  • 1. Targeting human telomerase by antisense oligonucleotides and ribozymes.
    Folini M; Pennati M; Zaffaroni N
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase inhibitors.
    Rowley PT; Tabler M
    Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapies.
    Folini M; Zaffaroni N
    Curr Pharm Des; 2005; 11(9):1105-17. PubMed ID: 15853659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymes.
    Zaffaroni N; Villa R; Pennati M; Folini M
    Mini Rev Med Chem; 2003 Feb; 3(1):51-60. PubMed ID: 12570854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase: a target for cancer therapeutics.
    Shay JW; Wright WE
    Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeres and telomerases as drug targets.
    Rezler EM; Bearss DJ; Hurley LH
    Curr Opin Pharmacol; 2002 Aug; 2(4):415-23. PubMed ID: 12127874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase inhibition in cancer therapeutics: molecular-based approaches.
    Cunningham AP; Love WK; Zhang RW; Andrews LG; Tollefsbol TO
    Curr Med Chem; 2006; 13(24):2875-88. PubMed ID: 17073634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibitors as anticancer therapy.
    Akiyama M; Hideshima T; Munshi NC; Anderson KC
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
    Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; S├ęgal-Bendirdjian E
    Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase as an anti-cancer target: current status and future prospects.
    Neidle S; Kelland LR
    Anticancer Drug Des; 1999 Aug; 14(4):341-7. PubMed ID: 10625926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
    Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
    Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent patents on anti-telomerase cancer therapy.
    Agrawal A; Dang S; Gabrani R
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):102-17. PubMed ID: 21854360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.
    Herbert B; Pitts AE; Baker SI; Hamilton SE; Wright WE; Shay JW; Corey DR
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14276-81. PubMed ID: 10588696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
    Diala I; Shiohama Y; Fujita T; Kotake Y; Demonacos C; Krstic-Demonacos M; Leva GD; Fujii M
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):407-425. PubMed ID: 32310030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase inhibitors: targeting the vulnerable end of cancer?
    Kelland LR
    Anticancer Drugs; 2000 Aug; 11(7):503-13. PubMed ID: 11036953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere inhibition and telomere disruption as processes for drug targeting.
    Rezler EM; Bearss DJ; Hurley LH
    Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.